Ipca Laboratories Limited (BOM:524494)

Revenue by Product

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005
Branded Generics	44.62B
Branded Generics Growth	18.62%
Generics	29.29B
Generics Growth	23.69%
Active Pharmaceutical Ingredients	14.64B
Active Pharmaceutical Ingredients Growth	-1.95%
Export Incentives	479.30M
Export Incentives Growth	-1.32%
Miscellaneous	208.90M
Miscellaneous Growth	23.83%
Scrap	158.90M
Scrap Growth	-3.93%
Sundry Balances Written Back	2.80M
Sundry Balances Written Back Growth	-56.92%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005
India	39.60B
India Growth	9.58%
United States	14.46B
Europe	13.88B
Europe Growth	58.05%
Africa	5.95B
Africa Growth	12.05%
Americas	4.64B
Americas Growth	-65.83%
Asia	4.59B
Asia Growth	-0.94%
Australasia	2.83B
Australasia Growth	-8.39%
Commonwealth of Independent States	2.58B
Commonwealth of Independent States Growth	1.18%